Brief: Dongsung Pharmaceutical lowers conversion price of 30th series convertible bonds to 4,252 won/share
Jan 12 (Reuters) - Dongsung Pharmaceutical Co Ltd
002210.KS :
* Says it lowered conversion price of 30th series
unregistered and unsecured private convertible bonds to 4,252
won/share from 4,977 won/share, effective Jan. 12
Source text in Korean: https://goo.gl/JYLbGL
Further company coverage: 002210.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Dongsung Pharmaceutical Co
See all newsBrief: Dongsung Pharmaceutical To Divest 7 Billion Won Worth Of Own Shares
Brief: Dongsung Pharmaceutical To Conduct Capital Increase Of 2 Billion Won For Operational Funds
Brief: Dongsung Pharmaceutical To Divest 2.2 Billion Won Worth Of Own Shares
Brief: Dongsung Pharmaceutical Wins 7.8 Billion Won Order
Brief: Dongsung Pharmaceutical To Divest 3 Billion Won Worth Of Own Shares